Pharmafile Logo
Pharmafocus logo
Advanced Search
novartis_side_building

Novartis set to offer 14 weeks paternity leave

March 5, 2019
Manufacturing and Production Novartis, company culture, paternity leave, work

Novartis is planning to offer employees 14 weeks of parental leave, a move which would make the firm one of …

News
1920px-hiv-budding-color

London man becomes second in world to be cured of HIV

March 5, 2019
Manufacturing and Production Berlin Patient, CCR5, HIV, He Jiankui, London Patient

A man in Britain has become the second person in the world to be ‘cured’ of HIV, after receiving a …

News
novartis_side_building

Novartis’ Cosentyx tops Janssen’s Stelara in moderate-to-severe psoriasis trial

March 5, 2019
Manufacturing and Production, Research and Development Cosentyx, Janssen, Novartis, Stelara, pharma, psoriasis

New data has been revealed in support of Novartis’ Cosentyx (secukinumab) in the treatment of moderate-to-severe plaque psoriasis, demonstrating the …

News
920x920

OxyContin drugmaker Purdue Pharma exploring bankruptcy, sources say

March 4, 2019
Manufacturing and Production Litigation, Purdue Pharma, bankruptcy, opioid crisis, trials

OxyContin drugmaker Purdue Pharma is exploring the option of filing for bankruptcy. The news comes as the Connecticut-based firm faces …

News

The cutting edge of cancer research

March 4, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, feature, oncology

While immunotherapies continue to be the darling of the industry, new, innovative and sometimes seemingly fantastical research is emerging that …

Feature
abbvie_0

AbbVie’s Skyrizi scoops up CHMP recommendation for moderate to severe plaque psoriasis

March 4, 2019
Sales and Marketing AbbVie, pharma, psoriasis

AbbVie’s interleukin-23 (IL-23) inhibitor Skyrizi (risankizumab) has secured recommendation from the EMA’s Committee for Medicinal Products for Human Use (CHMP), …

News

Indian government set to colour code generic medicines

March 4, 2019
Sales and Marketing India, Indian health, costs, generic medicines, pricing, sales

As part of an effort to promote low cost medicines, the Indian government has announced plans to colour code generic …

News
natural-homeopathic-remedy-alternative-homeopathy-1604071

Doctors call on Canadian government to stop funding programme sending homeopaths to Honduras

March 4, 2019
Sales and Marketing Canada, Hodnuras, Quebec, TSF, health, homeopathy

Canadian physicians have called on the federal government to review its funding for a programme which sends volunteer homeopaths to …

News

Biogen boosts ophthalmology portfolio with $800m acquisition of gene therapy firm Nightstar

March 4, 2019
Sales and Marketing Biogen, Nightstar, acquisition, pharma

Biogen has announced it has inked an agreement to acquire clinical-stage gene therapy firm Nightstar for a total value of …

News

NHS chief warns of rise of anti-vaccine ‘fake news’ online

March 4, 2019
Sales and Marketing NHS, NHS England, Simon Stevens, anti vaxxer, fake news, vaccines

The head of NHS England has warned that ‘vaccination deniers’ are increasing their influence on social media through ’fake news’. …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

March 1, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GP, Michael Cohen, Novartis, Roche, Sanofi, Senate, UK, crispr, top 10

As the CRISPR twins’ story unfolds, scientists revealed that the Chinese babies were likely altered in a way that improves …

News
bernie_in_phoenix_2015_2

Bernie Sanders calls on FDA to allow generic, low cost versions of Catalyst Pharma’s $375,000 rare disease drug

March 1, 2019
Medical Communications Bernie Sanders, Catalyst Pharmaceuticals Jacobus

US Senator Bernie Sanders has called on regulators to allow pharmacies and manufacturers to distribute generic versions of Catalyst Pharmaceuticals’ …

News

J&J sign deal with Scottish firm AdoRx to develop novel lung cancer treatments

March 1, 2019
Medical Communications AdoRx, Cancer, Cancer Immunotherapy, J&J, JJ, immunology, oncology

Edinburgh-based drug discovery firm AdoRx therapeutics has signed a deal with US healthcare conglomerate Johnson & Johnson to develop novel …

News

Philippines Department of Justice recommends charges against six Sanofi officials

March 1, 2019
Medical Communications Philippines, Sanofi, dengue, dengvaxia, vaccines

The Philippine Justice Ministry has said it has found probably cause to charge officials working for French drugmaker Sanofi over …

News

Nearly half of childhood cancer cases go untreated and undiagnosed

March 1, 2019
Medical Communications Cancer, childhood cancer, diagnosis, oncology, pediatric, world

Almost half of all children with cancer are going untreated and undiagnosed, according to research published in Lancet Oncology. While …

News
8b437d43644106a4fb11aa4292aa6fbd_1

Working Life: Nicola Redfern, UK General Manager, bluebird bio

February 28, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bluebird Bio, Interview, Working Life, pharma

How did you find your way into the pharma industry? Was it always an aspiration of yours? My mum worked …

Feature
shutterstock_138095450

Disapproval from top shareholder throws $74bn BMS/Celgene merger into doubt

February 28, 2019
Sales and Marketing Bristol-Myers Squibb, Celgene, acquisition, pharma

The news kicked off 2009 with a bang when Bristol-Myers Squibb announced it intended to acquire Celgene for $74 billion, …

News

More than 40% of GPs intend to quit within five years

February 28, 2019
Medical Communications GPs, NHS, NHS LOng term plan, UK, brexit, workforce

More than 40% of GPs intend to quit within five years according to researchers at the University of Warwick. The …

News
michael_cohen_-_chip_somodevilla_-_getty_images

Trump ex-lawyer Cohen reveals Novartis pushed him to lobby

February 28, 2019
Sales and Marketing Donald Trump, Michael Cohen, Novartis, US, pharma

Among the swirling storm emanating from the testimony of Donald Trump’s ex-lawyer Michael Cohen to the House Oversight Committee, one …

News
medicinal_cannabis_uk_review

Scientists genetically modify yeast to produce CBD and THC

February 28, 2019
Research and Development Medical marijuana, berkely, cannabis, science, yeast

Researchers at the University of California, Berkeley have genetically modified brewer’s yeast so that it produces two common cannabinoids: tetrahydrocannabinol …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026